阿芬太尼联合丙泊酚麻醉在儿童口腔舒适化治疗中的应用

何泽秀 ,  张贤亮 ,  靳秋芳 ,  刘子豪 ,  孟凡勇 ,  林瑞华

中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (9) : 825 -829.

PDF (396KB)
中国医科大学学报 ›› 2026, Vol. 55 ›› Issue (9) : 825 -829. DOI: 10.12007/j.issn.0258‐4646.2026.09.010
论著

阿芬太尼联合丙泊酚麻醉在儿童口腔舒适化治疗中的应用

作者信息 +

Application of anesthesia with alfentanil combined with propofol in comfortable dental treatment in children

Author information +
文章历史 +
PDF (404K)

摘要

目的 探讨阿芬太尼联合丙泊酚麻醉在儿童口腔舒适化治疗中的应用效果与安全性。方法 采取前瞻性、随机对照方法,选取2025年3月至12月于河北医科大学口腔医院麻醉科接受择期口腔舒适化治疗的3~16岁患儿120例,按照随机数字表法分成阿芬太尼组 (阿芬太尼联合丙泊酚麻醉) 和瑞芬太尼组 (瑞芬太尼联合丙泊酚麻醉),每组60例。比较2组患儿术中生命体征及血流动力学指标、丙泊酚用量、麻醉总维持时间、自主呼吸恢复时间、清醒时间;停止输注丙泊酚后30 min Aldrete评分、达标离院时间以及围手术期不良反应发生情况。结果 2组患儿性别、年龄、ASA分级、手术类型等基本临床指标比较差异无统计学意义 (P > 0.05)。与瑞芬太尼组相比,阿芬太尼组丙泊酚总用量明显减少,术中最低平均动脉压和最低脉搏血氧饱和度显著增高,自主呼吸恢复时间、清醒时间、达标离院时间显著缩短,停止输注丙泊酚后30 min Aldrete评分更高 (P < 0.05)。2组麻醉维持时间和术中平均动脉压比较差异无统计学意义 (P > 0.05)。围手术期恶心/呕吐、肢体躁动、呼吸抑制及皮肤瘙痒等不良反应发生率阿芬太尼组低于瑞芬太尼组,但2组比较差异无统计学意义 (P > 0.05)。结论 在儿童口腔舒适化治疗中使用阿芬太尼联合丙泊酚麻醉,在保证麻醉效果的同时可减少丙泊酚用量,改善术中氧合情况,加快患儿术后恢复及离院进程。

Abstract

Objective To investigate the efficacy and safety of anesthesia with alfentanil combined with propofol in comfortable dental treatment in children. Methods A prospective randomized controlled study was conducted. A total of 120 children aged 3 to 16 years,who were scheduled for elective comfortable dental treatment between March 2025 and December 2025,were included and randomly divided into the alfentanil group (anesthesia with alfentanil combined with propofol) and the remifentanil group (anesthesia with remifentanil combined with propofol) using a random number table method,with 60 cases in each group. Intraoperative vital signs and hemodynamic parameters,total propofol consumption,anesthesia maintenance time,time to recovery of spontaneous respiration,awakening time,Aldrete scores at 30 min after propofol discontinuation,time to discharge readiness,and perioperative adverse events were compared between the two groups. Results There were no significant differences in baseline clinical characteristics,including sex,age,American Society of Anesthesiologists (ASA) grade,and treatment type between the two groups (P > 0.05). Compared with the remifentanil group,the alfentanil group showed significantly lower total propofol consumption;significantly higher intraoperative minimum mean arterial pressure and minimum pulse oxygen saturation;significantly shorter time to recovery of spontaneous respiration,awakening time,and time to discharge readiness;and significantly higher Aldrete score at 30 min after propofol discontinuation (P < 0.05). There were no significant differences in anesthesia maintenance time or intraoperative mean arterial pressure between the two groups (P > 0.05). The incidences of perioperative adverse events,including nausea/vomiting,limb agitation,respiratory depression,and pruritus,were lower in the alfentanil group than in the remifentanil group;however,the differences were not statistically significant (P > 0.05). Conclusion Anesthesia with alfentanil combined with propofol for comfortable dental treatment in children can reduce propofol consumption,improve intraoperative oxygenation,and accelerate postoperative recovery while maintaining adequate anesthetic efficacy.

关键词

阿芬太尼 / 瑞芬太尼 / 丙泊酚 / 口腔舒适化治疗 / 儿童

Key words

alfentanil / remifentanil / propofol / comfortable dental treatment / children

引用本文

引用格式 ▾
何泽秀,张贤亮,靳秋芳,刘子豪,孟凡勇,林瑞华. 阿芬太尼联合丙泊酚麻醉在儿童口腔舒适化治疗中的应用[J]. 中国医科大学学报, 2026, 55(9): 825-829 DOI:10.12007/j.issn.0258‐4646.2026.09.010

登录浏览全文

4963

注册一个新账户 忘记密码

参考文献

[1]

KASSEM EL HAJJ H,FARES Y,ABOU-ABBAS L. Assessment of dental anxiety and dental phobia among adults in Lebanon [J]. BMC Oral Health,2021,21:48. DOI:10.1186/s12903-021-01409-2.

[2]

POHJOLA V,REKOLA A,KUNTTU K,et al. Association between dental fear and oral health habits and treatment need among University students in Finland:a national study [J]. BMC Oral Health,2016,16:26. DOI:10.1186/s12903-016-0179-y.

[3]

ENKLING N,MARWINSKI G,JÖHREN P. Dental anxiety in a representative sample of residents of a large German city [J]. Clin Oral Investig,2006,10 (1):84-91. DOI:10.1007/s00784-006-0035-6.

[4]

AMERICAN ACADEMY OF PEDIATRIC DENTISTRY CLINICAL AFFAIRS COMMITTEE - SEDATION AND GENERAL ANESTHESIA SUBCOMMITTEE. Guideline on use of anesthesia personnel in the administration of office-based deep sedation/general anesthesia to the pediatric dental patient [J]. Pediatr Dent,2012,34 (5):170-172.

[5]

张超,赵楠,郁葱. 镇痛优先:口腔舒适化诊疗的新进展 [J]. 国际口腔医学杂志,2026,53 (1):1-9. DOI:10.7518/gjkq.2026001.

[6]

周玭娉,郁葱. 保障口腔门诊舒适化医疗安全高效运行的措施 [J]. 中国实用口腔科杂志,2019,12 (11):641-647. DOI:10.19538/j.kq.2019.11.001.

[7]

TOBIAS JD,LEDER M. Procedural sedation:a review of sedative agents,monitoring,and management of complications [J]. Saudi J Anaesth,2011,5 (4):395-410. DOI:10.4103/1658-354X.87270.

[8]

PAVLIN DJ,CODA B,SHEN DD,et al. Effects of combining propofol and alfentanil on ventilation,analgesia,sedation,and emesis in human volunteers [J]. Anesthesiology,1996,84 (1):23-37. DOI:10.1097/00000542-199601000-00004.

[9]

ZHAO N,ZENG J,FAN L,et al. Moderate sedation by total intravenous remimazolam-alfentanil vs. propofol-alfentanil for third molar extraction:a prospective randomized controlled trial [J]. Front Med,2022,9:950564. DOI:10.3389/fmed.2022.950564.

[10]

PHILIP BK,SCUDERI PE,CHUNG F,et al. Remifentanil compared with alfentanil for ambulatory surgery using total intravenous anesthesia [J]. Anesth Analg,1997,84 (3):515-521. DOI:10.1097/00000539-199703000-00009.

[11]

RAMSAY MA,SAVEGE TM,SIMPSON BR,et al. Controlled sedation with alphaxalone-alphadolone [J]. Br Med J,1974,2 (5920):656-659. DOI:10.1136/bmj.2.5920.656.

[12]

FUENTES R,CORTÍNEZ I,IBACACHE M,et al. Propofol concentration to induce general anesthesia in children aged 3-11 years with the Kataria effect-site model [J]. Paediatr Anaesth,2015,25 (6):554-559. DOI:10.1111/pan.12657.

[13]

COTÉ CJ,WILSON S,PEDIATRICS AAO,et al. Guidelines for monitoring and management of pediatric patients before,during,and after sedation for diagnostic and therapeutic procedures [J]. Pediatrics,2019,143 (6):e20191000. DOI:10.1542/peds.2019-1000.

[14]

ASHLEY PF,CHAUDHARY M,LOURENÇO-MATHARU L. Sedation of children undergoing dental treatment [J]. Cochrane Database Syst Rev,2018,12 (12):CD003877. DOI:10.1002/14651858.CD003877.pub5.

[15]

CHEN SC,CHEN CY,SHEN SJ,et al. Application of bispectral index system (BIS) monitor to ambulatory pediatric dental patients under intravenous deep sedation [J]. Diagnostics (Basel),2023,13 (10):1789. DOI:10.3390/diagnostics13101789.

[16]

ZIESENITZ VC,VAUGHNS JD,KOCH G,et al. Pharmacokinetics of fentanyl and its derivatives in children:a comprehensive review [J]. Clin Pharmacokinet,2018,57 (2):125-149. DOI:10.1007/s40262-017-0569-6.

[17]

AVRAMOV MN,WHITE PF. Use of alfentanil and propofol for outpatient monitored anesthesia care:determining the optimal dosing regimen [J]. Anesth Analg,1997,85 (3):566-572. DOI:10.1097/00000539-199709000-00015.

[18]

ZHAO N,ZENG J,FAN L,et al. The effect of alfentanil on emergence delirium following general anesthesia in children:a randomized clinical trial [J]. Paediatr Drugs,2022,24 (4):413-421. DOI:10.1007/s40272-022-00510-5.

[19]

CHO JS,SOH S,KIM EJ,et al. Comparison of three sedation regimens for drug-induced sleep endoscopy [J]. Schlaf Atmung,2015,19 (2):711-717. DOI:10.1007/s11325-015-1127-9.

[20]

KOCAOGLU MH,VURAL C. Assessing discharge readiness after propofol-mediated deep sedation in pediatric dental procedures:revisiting discharge practices with the modified aldrete recovery score [J]. Children (Basel),2025,12 (9):1155. DOI:10.3390/children12091155.

基金资助

河北省医学科学研究课题计划(20231108)

AI Summary AI Mindmap
PDF (396KB)

0

访问

0

被引

详细

导航
相关文章

AI思维导图

/

〈 〉